Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs IHE overlap: 42% of top holdings shared

Bottom line

How much do XLV and IHE overlap?

42% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 37.1% of XLV's assets and 57.6% of IHE's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

XLVIHE
Weight overlap (top 25)42%
Shared holdings5
Weight in shared holdings37.1%57.6%
Total positions6559
Expense ratio0.08%0.37%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings XLV and IHE have in common

Holding% of XLV% of IHEOverlap
Eli Lilly & Co16.51%22.25%16.51%
Johnson & Johnson10.64%22.44%10.64%
Merck & Co Inc5.52%4.55%4.55%
Pfizer Inc2.39%3.96%2.39%
Bristol-Myers Squibb Co2.05%4.37%2.05%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. AbbVie Inc — 7.74%
  2. UnitedHealth Group Inc — 6.57%
  3. Amgen Inc — 3.40%
  4. Thermo Fisher Scientific Inc — 3.24%
  5. Abbott Laboratories — 2.75%
  6. Gilead Sciences Inc — 2.73%
  7. Intuitive Surgical Inc — 2.45%
  8. CVS Health Corp — 2.30%
  9. Vertex Pharmaceuticals Inc — 2.19%
  10. Danaher Corp — 2.09%
  11. Stryker Corp — 1.89%
  12. Medtronic PLC — 1.75%
  13. McKesson Corp — 1.58%
  14. Elevance Health Inc — 1.46%
  15. Cigna Group/The — 1.27%

Only in IHE

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  2. Royalty Pharma Plc — 4.34%
  3. Viatris Inc. — 4.22%
  4. Zoetis Inc. — 3.73%
  5. Jazz Pharmaceuticals Public Limited Company — 3.45%
  6. Elanco Animal Health Incorporated — 2.81%
  7. Axsome Therapeutics, Inc. — 2.42%
  8. Corcept Therapeutics Incorporated — 1.90%
  9. Ligand Pharmaceuticals Incorporated — 1.45%
  10. Definium Therapeutics Inc — 1.39%
  11. Liquidia Corp — 1.28%
  12. Indivior Pharmaceuticals, Inc. — 1.14%
  13. Crinetics Pharmaceuticals Inc — 0.90%
  14. Organon & Co. — 0.81%
  15. Edgewise Therapeutics Inc — 0.70%

Asset mix

Asset typeXLVIHE
Stocks99.7%99.9%
Cash & short-term funds0.3%6.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryXLVIHE
US97.9%96.4%
GB—4.3%
IE2.1%3.8%
CA—1.4%
SG—0.2%
KY—0.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do XLV and IHE overlap?
About 42% by weight. 5 securities appear in both funds' top 25 holdings; they make up 37.1% of XLV's assets and 57.6% of IHE's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and IHE have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Merck & Co Inc, Pfizer Inc, Bristol-Myers Squibb Co.
Should I own both XLV and IHE?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or IHE?
XLV is broader, with 65 positions versus 59 for IHE. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.